|
TROVE2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66344715779587E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.45883305435746E-12 |
| Normal-vs-Stage2 |
2.35889999999905E-06 |
| Normal-vs-Stage3 |
2.79280043535834E-10 |
| Normal-vs-Stage4 |
7.21349646681801E-11 |
| Stage1-vs-Stage2 |
3.914400E-01 |
| Stage1-vs-Stage3 |
6.742200E-01 |
| Stage1-vs-Stage4 |
9.014100E-02 |
| Stage2-vs-Stage3 |
2.933000E-01 |
| Stage2-vs-Stage4 |
3.375600E-02 |
| Stage3-vs-Stage4 |
2.164600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.26787469412193E-13 |
| Normal-vs-AfricanAmerican |
3.562600E-03 |
| Normal-vs-Asian |
5.86570014782239E-10 |
| Caucasian-vs-AfricanAmerican |
9.044400E-02 |
| Caucasian-vs-Asian |
4.131000E-01 |
| AfricanAmerican-vs-Asian |
4.041900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.65030261362654E-11 |
| Normal-vs-Female |
1.89837034980656E-12 |
| Male-vs-Female |
8.344600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.91849877598338E-11 |
| Normal-vs-Age(41-60Yrs) |
7.93809462606987E-14 |
| Normal-vs-Age(61-80Yrs) |
1.35920000032819E-07 |
| Normal-vs-Age(81-100Yrs) |
3.929800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.098400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.468600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.400200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.319500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.057800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.879600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.329230E-01 |
| Classical-VS-Follicular |
4.486800E-01 |
| Classical-VS-Other |
6.409400E-01 |
| Classical-VS-Normal |
2.40774067350458E-12 |
| Tall-VS-Follicular |
5.276100E-02 |
| Tall-VS-Other |
7.526200E-01 |
| Tall-VS-Normal |
3.93489996142193E-09 |
| Follicular-VS-Other |
5.270400E-01 |
| Follicular-VS-Normal |
6.88970000051192E-07 |
| Other-VS-Normal |
4.123400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.45494768747312E-12 |
| Normal-vs-N1 |
4.92272889118794E-12 |
| N0-vs-N1 |
6.244400E-02 |
|
|
